论文部分内容阅读
资本总是敏感且冲动。随着年年飚升的行业增长率,医药这个原本在中国就非常独特且复杂的行业,被紧随一项项政策解冻而蓬勃投入的资本力量搅得更加烟雾弥漫。据原国家经贸委的统计数据显示,在2002年淘汰了1000余家药企之后,截止2002年11月底,中国现有制药企业近4300家,其中国企约930家,集体企业5000余家,民营企业近700家,而三资企业达到1400多家。上市公司中以医药为主业的企业有近80家,此外另有百余家上市公司也有涉足医药行业。整个行业可谓一片锣鼓喧天。
Capital is always sensitive and impulsive. With industry soaring every year, medicine, a very unique and complex industry originally in China, was smoldered by the capitalist forces that followed a policy of thawing and booming. According to statistics from the former State Economic and Trade Commission, after the phase-out of more than 1,000 pharmaceutical companies in 2002, as of the end of November 2002, there were nearly 4,300 existing pharmaceutical enterprises in China, of which 930 were Chinese enterprises and more than 5,000 are collective enterprises Nearly 700 enterprises, while foreign-funded enterprises reached more than 1,400. Listed companies in the pharmaceutical industry, nearly 80 companies, in addition to another one hundred listed companies have also set foot in the pharmaceutical industry. The whole industry can be described as a percussion.